Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 19 years or older
- People who have been diagnosed with liver cancer (hepatocellular carcinoma) through imaging or biopsy, bile duct cancer within the liver (intrahepatic cholangiocarcinoma) confirmed by biopsy, or cancer that has spread to the liver from elsewhere
- People where at least 30% of the healthy (non-tumour) part of their liver would not be affected by the treatment
- People whose liver function falls into the "Child-Pugh class A" category, meaning relatively well-preserved liver function (confirm with trial site)
- People who are generally well enough to carry out light activity and care for themselves, as measured by a standard medical scale (ECOG performance status of 0 or 1)
- People whose lung shunt fraction is 20% or below on a specific pre-treatment scan (this measures how much of a substance bypasses the liver and goes to the lungs)
- People whose recent blood test results (within the last 2 months) show that major organ function is within acceptable ranges, including white blood cell count, haemoglobin, bilirubin, platelets, blood clotting, liver enzymes, and kidney function
- People with a life expectancy of at least 3 months
- Women who could become pregnant must have a negative blood pregnancy test before joining
- People who fully understand what the study involves and have provided written consent to participate
Who may not be able to join:
- People who have had a surgical connection between the bile ducts and the bowel, or who have a bile duct stent in place
- People whose lung scans show emphysema (damaged air sacs) or scarring/inflammation of the lung tissue, where the treating doctor judges that even mild radiation-related lung irritation could be life-threatening
- People who have previously had a severe allergic reaction to iodine-based contrast dye (the type used in certain medical scans)
- People for whom angiography (an imaging procedure involving blood vessels) or catheter-based procedures are medically unsuitable
- People whose lung shunt fraction is greater than 20% on the pre-treatment scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 82-10-5136-5205
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
• Difference between LSF calculated from MAA scan, LSF from scout Y90 PET/CT, and LSF from treatment Y90 PET/CT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.